2010
DOI: 10.1007/s00417-010-1497-4
|View full text |Cite
|
Sign up to set email alerts
|

Long-term follow-up of a supradescemetic keratoprosthesis in rabbits: an immunofluorescence study

Abstract: pHEMA-MMA(34) was clinically biocompatible, and did not induce any inflammatory reaction or scarring when implanted in the supradescemetic space. This material showed more promising biocompatibility results than for PMMA, whether implanted within the central cornea stroma or in the supradescemetic space.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2011
2011
2016
2016

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(8 citation statements)
references
References 18 publications
0
8
0
Order By: Relevance
“…The results of the in vivo biocompatibility evaluations conducted in this work are further strengthened by the fact that the rabbit eye is generally more sensitive than the human eye [39]. The rabbit cornea is thinner with a steeper curvature and is more susceptible to evaporative damage because of a slower blink frequency than a human eye [38].…”
Section: Discussionmentioning
confidence: 93%
See 1 more Smart Citation
“…The results of the in vivo biocompatibility evaluations conducted in this work are further strengthened by the fact that the rabbit eye is generally more sensitive than the human eye [39]. The rabbit cornea is thinner with a steeper curvature and is more susceptible to evaporative damage because of a slower blink frequency than a human eye [38].…”
Section: Discussionmentioning
confidence: 93%
“…Another factor strengthening our findings is that topical corticosteroids were given only for a few days postoperatively; standard clinical postoperative regimens might have masked inflammation in our rabbit experiments. In addition, the rabbit eye readily extrudes foreign material, limiting long-term studies beyond a few months [39]. Thus we believe that the present work is an important step toward testing these HMPEI-coated materials in humans.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, investigation of different forms of graphene (e.g., graphene oxide, reduced graphene oxide, and graphene-decorated flexible surfaces) with modified mechanical properties, as well as long-term in vivo behaviors of different graphene materials, are warranted to obtain a better understanding of its potential in clinical application. 51,52 Our initial findings have demonstrated great promise for GBMs in the development of ophthalmologic biomaterials.…”
Section: Discussionmentioning
confidence: 99%
“…Besides these facts, according to Pressler (2010), corneal allografts have still shown the best results in keratoplasty, however, they have limited supply and may not be readily available. Thus, biopolymers are becoming more studied in replacement of corneal tissue to retrieve the appropriate refractive status of the eye (Espana et al 2011). To be applied to the cornea, a material must be transparent, allowing epithelial growth on its surface, should not trigger an exaggerated immune response and should allow fibroplasia and deposition of extracellular matrix in the interface (Tanure 2006).…”
Section: Introductionmentioning
confidence: 99%